Permeability of dopamine D2 receptor agonist hordenine across the intestinal and blood-brain barrier in vitro
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Plos One 17 (2022) 6, e0269486, 1-20
- Event
-
Veröffentlichung
- (where)
-
Münster
- (who)
-
Universitäts- und Landesbibliothek Münster
- (when)
-
2022
- Creator
-
Hahn, Maria
Lindemann, Viktoria
Behrens, Matthias
Mulac, Dennis
Langer, Klaus
Esselen, Melanie
Humpf, Hans-Ulrich
- DOI
-
10.17879/71099686735
- URN
-
urn:nbn:de:hbz:6-31099735009
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:41 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hahn, Maria
- Lindemann, Viktoria
- Behrens, Matthias
- Mulac, Dennis
- Langer, Klaus
- Esselen, Melanie
- Humpf, Hans-Ulrich
- Universitäts- und Landesbibliothek Münster
Time of origin
- 2022
Other Objects (12)
Protease-activated receptor signaling in intestinal permeability regulation
Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
Discriminative learning occasioned by the administration of a dopamine agonist
The impact of bile on intestinal permeability of drug substances
Influence of secretory transporters on the intestinal permeability of cationic drugs
Sphingosine-1-phosphate receptor 4 regulates blood-brain barrier permeability and promotes a homeostatic endothelial phenotype
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Protease-activated receptor signaling in intestinal permeability regulation
Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
Discriminative learning occasioned by the administration of a dopamine agonist
The impact of bile on intestinal permeability of drug substances
Influence of secretory transporters on the intestinal permeability of cationic drugs
Sphingosine-1-phosphate receptor 4 regulates blood-brain barrier permeability and promotes a homeostatic endothelial phenotype
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Protease-activated receptor signaling in intestinal permeability regulation
Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
Discriminative learning occasioned by the administration of a dopamine agonist
The impact of bile on intestinal permeability of drug substances
Influence of secretory transporters on the intestinal permeability of cationic drugs
Sphingosine-1-phosphate receptor 4 regulates blood-brain barrier permeability and promotes a homeostatic endothelial phenotype
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan